STLN STARLING ONCOLO
$3.50
STARLING ONCOLO (STLN) Earnings News
Earnings press releases, previews and reviews for STARLING ONCOLO (STLN), newest first. Our most recent is review: Starling Oncology Misses on GAAP EPS, Beats on EBITDA, but a Capitation Guidance Cut Undercuts the Growth Story.
Thursday
November 5, 2026
10:25 PM ET
Starling Oncology Misses on GAAP EPS, Beats on EBITDA, but a Capitation Guidance Cut Undercuts the Growth Story
Earnings Whispers · Review
Thursday
November 5, 2026
4:06 PM ET
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Wednesday
October 28, 2026
9:32 PM ET
Starling Oncology's Q3 Test: Can Onboarding Costs Stay Contained Ahead of Its Fourth-Quarter Expansion?
Earnings Whispers · Preview
Monday
October 26, 2026
9:00 AM ET
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
Thursday
August 6, 2026
4:14 PM ET
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance